Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (Australia) November 11, 2025
Smart Chart Life Sciences & Pharma Radiotherapeutics on the Rise: Cracking the Supply Chain Code May 16, 2025
Executive Insights Healthcare The Race Is On: Winning Smart in the Intensifying GLP-1 Market in China May 15, 2025
Case Study Life Sciences & Pharma Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company March 31, 2025 A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…
Video / Webinar Healthcare Services Australia's Clinical Trials: Innovation and Growth February 24, 2025
Special Report Life Sciences & Pharma Content Management Strategies for Pharmaceutical Companies Navigating Omnichannel… January 6, 2025
